Overview
- Telus appointed TD Securities and Jefferies to advise on strategy and timing for monetizing Telus Health, including evaluating potential strategic partnerships and ownership structures.
- The company frames the health-unit review as part of a deleveraging plan, projecting net debt to adjusted EBITDA of about 3.4x for 2025, with goals of roughly 3.3x by end-2026 and 3.0x by end-2027.
- Telus Health serves more than 160 million lives in over 200 countries and territories and reported year-to-date Q3 2025 figures of $1.5 billion in operating revenue, $258 million in adjusted EBITDA and $99 million in cash flow.
- CEO Darren Entwistle says the preferred outcome is to bring in a strategic partner that adds complementary skills, customer reach and economic capacity to accelerate growth.
- Telus cautions there is no assurance the process will result in a transaction and notes any deal would require board approval, highlighting precedent from prior monetizations and health acquisitions.